Empiric Quinidine Therapy for Asymptomatic Brugada Syndrome: Time for a Prospective Registry

Overview

Journal Heart Rhythm

Publisher Elsevier

Specialty Cardiology & Vascular Diseases

Date 2009 Mar 3

PMID 19251219

Citations 31

Authors

Sami Viskin

Arthur A M Wilde

Hanno L Tan

Charles Antzelevitch

Wataru Shimizu

Bernard Belhassen

Affiliations

Soon will be listed here.

Citing Articles

Brugada syndrome update.

Xu T, Wang S, Wang J, Xing J Front Physiol. 2025; 15:1520008.

PMID: 39896197 PMC: 11782167. DOI: 10.3389/fphys.2024.1520008.

Artemisinin-Quinidine Combination for Suppressing Ventricular Tachyarrhythmia in an Ex Vivo Model of Brugada Syndrome.

Jeong H, Yoon N, Kim Y, Lee K, Park H J Korean Med Sci. 2025; 40(1):e2.

PMID: 39763307 PMC: 11707659. DOI: 10.3346/jkms.2025.40.e2.

Contributions of Israel to the field of clinical cardiac electrophysiology and implantable devices.

Belhassen B Heart Rhythm O2. 2024; 5(2):67-84.

PMID: 38545322 PMC: 10964379. DOI: 10.1016/j.hroo.2023.11.006.

Genetic and Molecular Mechanisms in Brugada Syndrome.

Moras E, Gandhi K, Narasimhan B, Brugada R, Brugada J, Brugada P Cells. 2023; 12(13).

PMID: 37443825 PMC: 10340412. DOI: 10.3390/cells12131791.

Evaluating the Impact of Sex and Gender in Brugada Syndrome.

J Innov Card Rhythm Manag. 2020; 10(2):3530-3535.

PMID: 32479580 PMC: 7252688. DOI: 10.19102/icrm.2019.100205.

References

Chen Q, Kirsch G, Zhang D, Brugada R, Brugada J, Brugada P . Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature. 1998; 392(6673):293-6. DOI: 10.1038/32675. View

Watanabe H, Koopmann T, Scouarnec S, Yang T, Ingram C, Schott J . Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest. 2008; 118(6):2260-8. PMC: 2373423. DOI: 10.1172/JCI33891. View

Moss A, Shimizu W, Wilde A, Towbin J, Zareba W, Robinson J . Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation. 2007; 115(19):2481-9. PMC: 3332528. DOI: 10.1161/CIRCULATIONAHA.106.665406. View

Viskin S . Long QT syndromes and torsade de pointes. Lancet. 1999; 354(9190):1625-33. DOI: 10.1016/S0140-6736(99)02107-8. View

Jackman W, Friday K, Anderson J, Aliot E, Clark M, LAZZARA R . The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis. 1988; 31(2):115-72. DOI: 10.1016/0033-0620(88)90014-x. View

Brugada P, Brugada R, Brugada J . Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing?. Circulation. 2005; 112(2):279-92. DOI: 10.1161/CIRCULATIONAHA.104.485326. View

Viskin S, Barron H, Heller K, Scheinman M, Olgin J . The treatment of atrial fibrillation: pharmacologic and nonpharmacologic strategies. Curr Probl Cardiol. 1997; 22(2):37-108. DOI: 10.1016/s0146-2806(97)80014-x. View

London B, Michalec M, Mehdi H, Zhu X, Kerchner L, Sanyal S . Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias. Circulation. 2007; 116(20):2260-8. PMC: 3150966. DOI: 10.1161/CIRCULATIONAHA.107.703330. View

. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997; 337(22):1576-83. DOI: 10.1056/NEJM199711273372202. View

10.

Belhassen B, Shapira I, Sheps D, Laniado S . Programmed ventricular stimulation using up to two extrastimuli and repetition of double extrastimulation for induction of ventricular tachycardia: a new highly sensitive and specific protocol. Am J Cardiol. 1990; 65(9):615-22. DOI: 10.1016/0002-9149(90)91040-d. View

11.

Brugada P, Brugada R, Mont L, Rivero M, Geelen P, Brugada J . Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart. J Cardiovasc Electrophysiol. 2003; 14(5):455-7. DOI: 10.1046/j.1540-8167.2003.02517.x. View

12.

Schwartz P . The idiopathic long QT syndrome: the need for a prospective registry. Eur Heart J. 1983; 4(8):529-31. DOI: 10.1093/oxfordjournals.eurheartj.a061517. View

13.

Rosso R, Glick A, Glikson M, Wagshal A, Swissa M, Rosenhek S . Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU). Isr Med Assoc J. 2008; 10(6):435-9. View

14.

Villain E, Denjoy I, Lupoglazoff J, Guicheney P, Hainque B, Lucet V . Low incidence of cardiac events with beta-blocking therapy in children with long QT syndrome. Eur Heart J. 2004; 25(16):1405-11. DOI: 10.1016/j.ehj.2004.06.016. View

15.

Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D . Brugada syndrome: report of the second consensus conference. Heart Rhythm. 2005; 2(4):429-40. DOI: 10.1016/j.hrthm.2005.01.005. View

16.

Schulze-Bahr E, Eckardt L, Breithardt G, Seidl K, Wichter T, Wolpert C . Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease. Hum Mutat. 2004; 21(6):651-2. DOI: 10.1002/humu.9144. View

17.

Schwartz P, PERITI M, Malliani A . The long Q-T syndrome. Am Heart J. 1975; 89(3):378-90. DOI: 10.1016/0002-8703(75)90089-7. View

18.

Ohgo T, Okamura H, Noda T, Satomi K, Suyama K, Kurita T . Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation. Heart Rhythm. 2007; 4(6):695-700. DOI: 10.1016/j.hrthm.2007.02.014. View

19.

Kusano K, Taniyama M, Nakamura K, Miura D, Banba K, Nagase S . Atrial fibrillation in patients with Brugada syndrome relationships of gene mutation, electrophysiology, and clinical backgrounds. J Am Coll Cardiol. 2008; 51(12):1169-75. DOI: 10.1016/j.jacc.2007.10.060. View

20.

Marquez M, Salica G, Hermosillo A, Pastelin G, Gomez-Flores J, Nava S . Ionic basis of pharmacological therapy in Brugada syndrome. J Cardiovasc Electrophysiol. 2007; 18(2):234-40. DOI: 10.1111/j.1540-8167.2006.00681.x. View